A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy

The therapeutic potential of recombinant cytokines has been limited by the severe side effects of systemic administration. We describe a strategy to reduce the dose-limiting toxicities of monomeric cytokines by designing two components that require colocalization for activity and that can be indepen...

Descripción completa

Detalles Bibliográficos
Autores principales: Quijano-Rubio, Alfredo, Bhuiyan, Aladdin M., Yang, Huilin, Leung, Isabel, Bello, Elisa, Ali, Lestat R., Zhangxu, Kevin, Perkins, Jilliane, Chun, Jung-Ho, Wang, Wentao, Lajoie, Marc J., Ravichandran, Rashmi, Kuo, Yun-Huai, Dougan, Stephanie K., Riddell, Stanley R., Spangler, Jamie B., Dougan, Michael, Silva, Daniel-Adriano, Baker, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110466/
https://www.ncbi.nlm.nih.gov/pubmed/36316485
http://dx.doi.org/10.1038/s41587-022-01510-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110466/
https://www.ncbi.nlm.nih.gov/pubmed/36316485
http://dx.doi.org/10.1038/s41587-022-01510-z

Ejemplares similares